Clinical Trials Using Bavituximab
Clinical trials are research studies that involve people. The clinical trials on this list are studying Bavituximab. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
This study evaluates the combination of bavituximab and pembrolizumab in the treatment of gastric and gastroesphogeal cancer. All patients will receive both bavituximab, a drug that is not yet approved by the FDA, and pembrolizumab known as Keytruda. There is no expanded access program available for the investigational agents per this protocol.
Location: 2 locations
Pembrolizumab and Bavituximab in Treating Participants with Locally Advanced or Metastatic Liver Cancer
This phase II trial studies how well pembrolizumab and bavituximab work in treating participants with liver cancer that has spread to nearby tissues or lymph nodes or other places in the body. Monoclonal antibodies, such as pembrolizumab and bavituximab, may interfere with the ability of tumor cells to grow and spread.
Location: UT Southwestern / Simmons Cancer Center-Dallas, Dallas, Texas